Immediate Impact
3 from Science/Nature 85 standout
Citing Papers
Oesophageal cancer
2024 Standout
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
2023 Standout
Works of Gerhard Förster being referenced
Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial
2009 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Gerhard Förster | 741 | 25 | 34 | 370 | 303 | 24 | 1.0k | |
| Javier Gutiérrez Santamarı́a | 588 | 1 | 5 | 434 | 313 | 26 | 860 | |
| Gordana Verstovsek | 249 | 3 | 11 | 366 | 499 | 28 | 990 | |
| Susanne Arbogast | 563 | 35 | 390 | 368 | 26 | 1.4k | ||
| Czesław Osuch | 674 | 3 | 147 | 494 | 27 | 978 | ||
| Luisa Toffolatti | 633 | 17 | 273 | 249 | 42 | 1.1k | ||
| Zeng-Feng Wang | 664 | 1 | 30 | 343 | 394 | 17 | 1.2k | |
| Isam Eltoum | 497 | 2 | 522 | 439 | 26 | 1.2k | ||
| Akiko Ohashi | 763 | 2 | 11 | 185 | 421 | 28 | 1.4k | |
| Lori Rink | 413 | 9 | 113 | 190 | 31 | 928 | ||
| C Sakakura | 307 | 13 | 265 | 362 | 28 | 975 |
All Works
Loading papers...